Less attention has been paid to the gender-specific needs of men compared with women's health care. It is time to increase awareness of, and reinvigorate interest in, men's health concerns and to enhance understanding, improve clinical care and help set health policy goals for men's health. Fortunately, men's health has come to the forefront in the world and China is no exception. However, as a developing country with a long history and a versatile traditional culture, China has some unique definitions and emphases that differ from those of Western countries, so far as men's health is concerned. Three topics will be chosen for discussion in this article on the theme of men's health in China: erectile dysfunction, the most embarrassing topic; partial androgen deficiency of the ageing male, the most ignored topic; and prostate cancer, the most pressing topic. Moreover, the emphasis for these topics will focus on the differences between China and Western countries.
Get full access to this article
View all access options for this article.
References
1.
Agency for Healthcare Research and Quality. AHRQ focus on research: Issues in men's health care. Avaliable at: www://ahrq.gov/news/focus/menshc.htm. Accessed December22, 2005.
2.
National Center for Health Statistics. Overweight, obesity and healthy weight among persons 20 years of age and over, according to sex, age, race, and Hispanic origin: United States, 1960–62, 1971–74, 1976–80, 1988–94, and 1999–2002. In: Health, United States, 2004. Hyattsville, MD: NCHS, 2004: Table 69, pp. 241. Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/Health_US/hus04tables/Table069.xls.
SuimingPan. The factors inhibited Chinese people to answer questions on sexuality. Presented at the annual conference of the Society of Scientific Studies on Sexuality, Pittsburgh, USA,
May 1–5, 1996
.
5.
JardinA, WagnerG, KhouryS, GiulianoF, Padam-NathanH, RosenR, et al.Recommendations of the 1st International Consultation on Erectile Dysfunction. Co-sponsored by the World Health Organization (WHO), International Consultation on Urological Diseases (ICUD) and Société Internationale d’Urologie (SIU), July 1–3, 1999, Paris2000, p. 713.
6.
TanH-M, NgC-J, LowW-Y, FisherW, SandM.Prevalence of erectile dysfunction and treatment: preliminary results from three countries in the Asian Men's Attitudes to Life Events and Sexuality Study (Asian MALES). Poster presented at the International Congress of Andrology, June 13–15, 2005. Seoul, Korea.
7.
JingLeng. The study of epidemiology of erectile dysfunction in 1582 Chinese men over 40 years old in Shanghai urban area. Chin J Androl, 2000; 14(1): 29–31.
8.
ZhangQingJiang. Male sexual function study in three Chinese cities on 2226 males. Chin J Androl, 2003; 17(3): 91–193.
9.
LowW-Y, TanH-M, NgC-J, FisherW, SandM.Does quality of life differ between men with and without erectile dysfunction? Preliminary results from three countries in the Asian Men's Attitudes to Life Events and Sexuality Study (Asian MALES). Poster presented at the International Congress of Andrology, June 13–15, 2005. Seoul, Korea.
10.
NgC-J, TanH-M, LowW-Y, FisherW, SandM.Prevalence of comorbidities in men with erectile dysfunction in the Asian Men's Attitudes to Life Events and Sexuality Study (Asian MALES): Preliminary results from three countries. Poster presented at the International Congress of Andrology, June 13–15, 2005. Seoul, Korea.
11.
WangWenJian. Traditional Chinese medical treatment to ED. Chin Gen Pract, 2002; 5(1): 19–20.
12.
QinGuoZheng. Regularity study on erectile dysfunction and biotypology of Chinese medicine. J Beijing Univ Tradit Chin Med, 2005; 28(4): 74–78.
13.
MatsumotoA.M.Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci, 2002; 57A:M76–M99.
14.
AraujoA.B., O’DonellA.B., BambillaD.J., SimpsonW.B., LongcopeC., MatsumotoA.M., et al.Prevalence and incidence of androgen deficiency in middle-age and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab, 2004; 89:5920–5926.
15.
McLaghlanR.I., AllanC.A.Defining the prevalence and incidence of androgen deficiency in aging men: where are the goal posts?. J Clin Endocrinol Metab, 2004; 89:5916–5919.
16.
FerriniR.L., Connor-BarrettE.Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol, 1998; 147:750–754.
17.
WuJinHua, ZhouQing-xin, ShenZhong-hai, BaoZhong-gen, WengYi-li, QianYan-fei. Epidemiological investigation of partial androgen deficiency in aging male (PADAM) in the Island Area. Dis Surveill, 2004; 21(4): 208–211.
18.
ZhouQingXin. Partial androgen deficiency in aging male (PADAM) in the ZhouShan. Chin Prev Med, 2006; 2:130–133.
19.
AndersonJ.K., FaulknerS., CranorC., BrileyJ., GevirtzF., RobertS., et al.Andropause: knowledge and perceptions among the general public and health care professionals. J Gerontol A Biol Sci Med Sci, 2002; 57(12): 793–796.
20.
LuShuMing. Epidemiological investigation of male menopause. Chin J Androl, 2002; 16(4): 321–324.
21.
GuoYingLu. Challenge for men's health in China. Chin J Androl, 2003; 9(1): 321–324.
22.
XieZuoGang. Clinical research of Huanshaodan on treating partial androgen deficiency in aging male. Zhejiang JITCWM, 2005; 12(15): 734–736.
23.
LuMing. Treatment of partial androgen deficiency of the ageing male (PADAM) with Zhonghe decoction (a report of 30 cases). Chin J Hum Sex, 2005; 14(9): 9–11.
24.
ZhengXueFeng, PeiLi. Clinical thinking on acupuncture-moxibustion treatment of partial androgen deficiency in aging men. Shanghai J Acu-mox, 2006; 25(4): 28–29.
25.
ParkinD.M.Global Cancer Statistics, 2002. CA Cancer J Clin, 2005; 55:74–108.
26.
LiuZhenWei. Incidence trends of prostate cancer in urban Shanghai. Chin J Health Stat, 2003; 6:335–337.
27.
ZhangWei. Trends analysis of common urologic neoplasm incidence of elderly people in Shanghai. Chin J Cancer, 2004; 24(1): 11–15.
28.
XuZhiBing. The incidence of prostatic carcinoma in Shanghai. Chin J Clin Med, 2003; 10(3): 344–346.
29.
JiangQinkang. An analysis of epidemiological feature of prostate cancer in the period 1980–1999 in Yangpu District, Shanghai. Bull Chin Cancer, 2002; 11(5): 263–264.
30.
WangLin. Epidemic trend of common malignancies from 1983 to 2001 in Yangpu District, Shanghai. Bull Chin Cancer, 2004; 11.
31.
HankeyB.F., FeuerE.J., CleggL.X., HayesR.B., LeglerJ.M., ProrokP.C., et al.Cancer surveillance series: interpreting trends in prostate cancer - part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst, 1999; 91:1017–1024.
ZhangYuanFang. The relation of PSA level and the diagnosis and treatment of prostate cancer. Contin Med Educ, 2006; 11:9–11.
34.
QiuChengXuan. Epidemiological characteristics of prostate cancer in Wuhan, China. Chin J Public Health, 1999; 5:47–49.
35.
QianWeiQing. Mortality from urinary and male genital diseases in the population of Shanghai Hongkou district in recent years. Chin J Urol, 2001; 22(11): 645–650.
36.
PeyromaureM., DebreB., MaoK., ZhangGuoQiang, HuangYiRan, SunYingHao, et al.Management of prostate cancer in China: a multicenter report of 6 institutions. J Urol, 2005; 174(5): 1794–1797.
37.
MurphyA.M., McKiernanJ.M., OlssonC.A.Controversies in prostate cancer screening. J Urol, 2004; 172:1822–1824.
38.
HullG.W., RabbaniF., AbbasF., WheelerT.M., KattanM.W., ScardinoP.T., et al.Cancer control with radical prostatectomy alone in 1000 consecutive cases. J Urol, 2002; 167:528–534.
39.
HuangYiRan. Clinical analysis of radical retropubic prostatectomy: a report of 132 cases. Chin J Surg, 2006; 44(6): 365–368.
40.
LiAiHua. Laparoscopic radical prostatectomy: an evaluation of 159 cases. Chin J Urol, 2005; 26(12): 816–819.
41.
ShaoQiang. A preliminary study of PSA level in 646 healthy men in Beijing. Natl Med J Chin, 2000; 80(8): 591–592.
42.
ZhouLiQun. Variation of serum PSA with age in benign prostatic hyperplasia patients. Chin J Urol, 2002; 23(5): 293.
